Eligibility criteria for clinical trials in AL amyloidosis result in exclusion of nearly half of real-world patients.

ABSTRACT:

SUBMITTER: Bellofiore C 

PROVIDER: S-EPMC12908192 | biostudies-literature | 2026 Feb

REPOSITORIES: biostudies-literature